CD274 and neoplasm: The process of testing entails the utilization of an FDA-approved companion diagnostic test, which is a qualitative IHC assay that employs anti-PD-L1 antibodies to identify PD-L1 protein levels in formalin-fixed paraffin-embedded (FFPE) tumor tissue.